Status | Study |
Active, not recruiting |
Study Name: Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans Condition: Crimean-Congo Hemorrhagic Fever Date: 2017-01-11 Interventions: Biological: KIRIM-KONGO-VAX Cr |
Recruiting |
Study Name: Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi Condition: Ebola Hemorrhagic Fever Date: 2016-09-14 Interventions: Procedure: blood sampling collection It is an observational study; no interventions are planned in the c |
Recruiting |
Study Name: Open Study of the Duration of Immunity After Vaccination With GamEvac Condition: Hemorrhagic Fever, Ebola Date: 2016-09-14 Interventions: Procedure: blood sampling collection It is an observational study; no interventions are planned in the c |
Recruiting |
Study Name: Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo Condition: Hemorrhagic Fever, Ebola Date: 2016-01-08 Interventions: Biological: Ad26.ZEBOV No vacc |
Recruiting |
Study Name: Safety, Tolerability and Immunogenicity Study of 2 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo Condition: Hemorrhagic Fever, Ebola Date: 2015-11-04 Interventions: Biological: Ad26.ZEBOV One 0.5 |
Recruiting |
Study Name: Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults Condition: Hemorrhagic Fever, Ebola Date: 2015-09-29 Interventions: Biological: Ad26.ZEBOV One 0.5 |
Completed |
Study Name: Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults Condition: Hemorrhagic Fever, Ebola Date: 2015-09-29 Interventions: Biological: HPIV3-EbovZ GP Vaccine Administered intranasally by a VaxINator device |
Enrolling by invitation |
Study Name: Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever Condition: Viral Hemorrhagic Fever Date: 2015-06-24 Interventions: Drug: Ribavirin Loading do |
Completed |
Study Name: STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola) Condition: Hemorrhagic Fever, Ebola Date: 2015-02-19 Interventions: Biological: rVSVΔG-ZEBOV The rVSVΔG-ZEBOV vaccine is comprised of a single recombinant VSV iso |
Active, not recruiting |
Study Name: Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda Condition: Hemorrhagic Fever, Ebola Date: 2015-01-29 Interventions: Biological: cAd3-EBOZ cAd3 vac |